Mizuho Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective reduced by Mizuho from $21.00 to $18.00 in a report issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the medical instruments supplier’s stock. Mizuho’s price objective indicates a potential upside of 15.68% from the stock’s previous close.

Several other analysts also recently issued reports on XRAY. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday. Finally, Barrington Research reduced their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $23.33.

DENTSPLY SIRONA Stock Up 3.7 %

XRAY stock opened at $15.56 on Thursday. The company has a market cap of $3.10 billion, a P/E ratio of -7.52, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a 52 week low of $14.77 and a 52 week high of $33.72. The company’s 50-day moving average price is $18.28 and its 200 day moving average price is $20.93. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the company’s stock in a transaction dated Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

Large investors have recently made changes to their positions in the business. Riverview Trust Co acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. Colonial Trust Co SC acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. MassMutual Private Wealth & Trust FSB increased its position in shares of DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 1,568 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.